Bayoeconomy yeChina, yakanangana nebhayotechnology uye zviwanikwa zvipenyu, inobata zvikamu zvakasiyana-siyana zvinosanganisira zvekurima, chikafu, mishonga yemishonga, michina yekurapa, mabasa ehutano, kuchengetedza kwezvakatipoteredza, uye zvekushandisa nemakemikari. Zvinoenderana nefungidziro, huwandu hwese hwehupfumi hweChina hunogona kusvika pakati peRMB 38 trillion uye RMB 50 matiriyoni panosvika 2035.
Kubva pakutanga kwezana ramakore rechi21, budiriro inokurumidza musainzi yehupenyu uye yemazuva ano biotechnology yakaramba ichigadzirisa chiono chebioeconomy. Kunyanya, biotechnology yakabuda sechishandiso chine simba chekugadzirisa matambudziko makuru epasi rose akadai sekushanduka kwemamiriro ekunze, kuchengetedzwa kwechikafu, kuzvimiririra kwesimba, uye kuchengetedza kwezvakatipoteredza. Mumakore achangopfuura, zviitiko zvaimbovepo pabepa chete zviri kuitika pamwero unokurumidza. Nekukurumidza kufambira mberi mukuvandudza, nguva yebioeconomy iri kusvika nekukurumidza.
Shanduko yepasi rose, yehurongwa hwave kuenderera mberi-inotaridzwa nekukosha kwezviwanikwa uye kugadzirwa kwemaindasitiri ebiotechnologies. Pane kubvumirana kuri kukura kwekuti biotechnology ichagadzira ramangwana rezvatinodya, kupfeka, kushandisa, uye maitiro atinovaka nyika yedu. Shanduko iyi inotarisirwa kugadziridza zvakanyanya kugadzirwa kwezvinhu nemararamiro, zvichipa chimiro chitsva chehupfumi chinofanana nehupfumi hwekurima, hwemaindasitiri uye hwedhijitari.
Chirevo cheMcKinsey & Kambani inoratidza kuti ingangoita makumi matanhatu muzana ezvekushandisa muhupfumi hwepasi rose anogona, mukufungidzira, kugadzirwa pachishandiswa biotechnology. Nepo kuziva chiono chizere kunogona kutora nguva, kunyangwe kufambira mberi zvishoma kwaizochinja kugovera uye kudiwa masimba, kugadziridza zvimiro zveindasitiri, uye nekupesvedzera maitiro evatengi.
Zvikamu zviviri zveBioeconomy:
- Maonero etekinoroji-anotungamirirwa nesainzi yehupenyu uye hutsva.
- A resource{{0}centric view yakanangana nezvinogonekazve uye zvinogoneka zviwanikwa zvebhayoloji.
Nyika dzakaita seUS, nyika dziri nhengo dzeEU, Japan, South Korea, Argentina, India, Malaysia, neSouth Africa dzakakoshesa bioenergy, bio{2}inoenderana nekuchengetedzwa kwemhoteredzo, uye bioinformatics, dzichitsvaga kukwidziridza zvadzinazvo kusimudzira budiriro yekumaruwa nehupfumi, kugadzira mabasa, kusimudzira kukwikwidzana kwepasi rose, uye kutsvaga kusimudzira kuburikidza neruzivo rwebiotechnology{3}
Kubva panguva yeChishanu-Yegore reChirongwa, China yakasimudzira kutengeserana kwebiotechnologies uye nekutsigira zvakasimba kusimukira kwebioindustry. Panguva iyoyo, bioindustry yaitsanangurwa kuti inosanganisira zvikamu zvinomwe zvikuru: biopharmaceuticals, biomedical engineering, bio-agriculture, bioenergy, bio-manufacturing, bio{5}}kuchengetedzwa kwezvakatipoteredza, uye bioservices-ichijekesa hunyanzvi hwekugadzira zvinhu, kubatanidza zviwanikwa zvezviwanikwa.
Bioeconomy neNhamba (sa2021):
- Biopharmaceuticals: RMB 4 trillion (~ 19% yehuwandu)
- Bio-kurima: RMB 9.9 tiririyoni (~47%)
- Bio-kugadzira: RMB 6.9 tiririyoni (~33%)
- "Bio+" zvikamu: hazvina basa asi zvakakwirira-zvinogona kukura
Yese bioeconomy chiyero muna 2021: RMB 20.8 trillion
Zvichienderana neanochengetedza, ari pakati nepakati, uye ane tarisiro, chiyero chakafungidzirwa cheBioeconomy yeChina ndechinotevera:
Mamiriro ezvinhu ane tariro anotora gwara-kukwidziridzwa kunotyairwa (semuenzaniso, kusarerekera kwekabhoni uye "Bio+" kubatanidzwa), ne bio-kugadzira inotsiva inosvika 30–40% yezvinhu zvakajairika. Sezvo hupfumi hwe "Bio +" huchikura, hunotarisirwa kubatsira zvakanyanya kuhupfumi hwese, huchisimbisa basa rayo sembiru yehungwaru hwemamiriro ehupfumi hweChina.
